Empa researcher Peter Nirmalraj wants to image proteins with unprecedented precision – and thus gain insights into the molecular pathogenesis of Alzheimer’s. This should pave the way for an earlier diagnosis of the dementia disorder via a simple blood test. Together with neurologists from the Kantonsspital St.Gallen, a successful pilot study has now been completed.